When should I initiate a GLP‑1 receptor agonist and at what time of day should the first dose be administered?

When to Start GLP-1 Receptor Agonists

Initiate GLP-1 receptor agonists when A1C remains above individualized goal despite metformin therapy, or as first injectable therapy before insulin in most patients with type 2 diabetes. 1

Clinical Decision Framework for Initiation Timing

Primary Indications for Starting GLP-1 RAs:

Risk-Based Approach:

• Moderate-to-high cardiovascular/kidney risk: Start GLP-1 RA when A1C is above goal on current therapy 2
• Established CVD or CKD: Prioritize GLP-1 RA with proven cardiovascular benefit regardless of A1C 1
• Lower risk patients: Generally avoid unless obesity is present and weight loss is a priority 2

Glycemic Threshold:

• When A1C remains 1.5-2.0% above individualized goal on current oral therapy 1
• Do not delay - avoid therapeutic inertia by reassessing every 3-6 months 1

Critical Timing Considerations:

When Injectable Therapy is Needed:

• GLP-1 RAs are preferred as first injectable over insulin in most cases 1, 3
• Exception: Use insulin first if:
  • Symptoms of hyperglycemia are present
  • A1C >10% (>86 mmol/mol) or blood glucose ≥300 mg/dL (≥16.7 mmol/L)
  • Type 1 diabetes is a diagnostic possibility 1

Real-World Timing Gap: Research shows patients often remain in poor glycemic control (A1C >7.0%) for a median of 13.5 months before GLP-1 RA initiation - this delay contradicts guidelines and increases complication risk 4. General practitioners delay even longer (17 months) compared to specialists (11 months) 4.

Time of Day for First Dose

The guidelines and evidence do not specify a particular time of day for initiating GLP-1 receptor agonists. The timing depends on the specific agent:

• Once-weekly formulations (semaglutide, dulaglutide, exenatide weekly): Can be administered at any time of day, with or without meals 5
• Once-daily formulations (liraglutide): Can be administered at any time, but consistency is recommended 5
• Twice-daily formulations (exenatide): Typically given before morning and evening meals 5
• Oral semaglutide: Must be taken on an empty stomach with minimal water, at least 30 minutes before first food/drink/other medications 5

Practical Dosing Strategy:

Start at the lowest dose and up-titrate slowly to minimize gastrointestinal side effects 3, 6. The specific starting dose varies by agent - refer to manufacturer prescribing information 1.

Common Pitfalls to Avoid:

1. Therapeutic inertia: Waiting >3-6 months to intensify therapy when A1C remains above goal 1, 4
2. Delaying GLP-1 RAs in high-risk patients: Those with established CVD/CKD should receive GLP-1 RAs with proven cardiovascular benefit early 1, 2
3. Starting with insulin instead of GLP-1 RA: Unless severe hyperglycemia or symptomatic, GLP-1 RAs are preferred first injectable 1, 3
4. Inadequate dose titration: Rapid up-titration increases gastrointestinal intolerance and discontinuation 3, 6